Methyltestosterone and Enbrel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methyltestosterone (methyltestosterone) and Enbrel (etanercept). Common drug interactions include injection site haemorrhage among females.

The phase IV clinical study analyzes what interactions people have when they take Methyltestosterone and Enbrel. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Methyltestosterone?

Methyltestosterone has active ingredients of methyltestosterone. eHealthMe is studying from 352 Methyltestosterone users. Check the latest studies of Methyltestosterone.

What is Enbrel?

Enbrel has active ingredients of etanercept. It is often used in rheumatoid arthritis. eHealthMe is studying from 664,678 Enbrel users. Check the latest studies of Enbrel.



On Jul, 08, 2026

47 people who take Methyltestosterone and Enbrel together, and have interactions are studied.

Methyltestosterone and Enbrel drug interactions.

What are the common drug interactions of Methyltestosterone and Enbrel, by gender? *:

female:

  1. Injection site haemorrhage (bleeding from injection site)
  2. Injection site reaction
  3. Abdominal pain
  4. Cough
  5. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  6. Diarrhoea
  7. Pruritus (severe itching of the skin)
  8. Pyrexia (fever)
  9. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

male:

n/a

What are the common drug interactions of Methyltestosterone and Enbrel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  2. Cough
  3. Lower respiratory tract infection
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  5. Rigors (an episode of shaking or exaggerated shivering)
  6. Sputum increased
  7. Vasodilatation (widening of blood vessels resulting from relaxation of smooth muscle cells within the vessel walls)

40-49:

  1. Injection site reaction
  2. Injection site haemorrhage (bleeding from injection site)
  3. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
  4. Diarrhoea
  5. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  6. Epistaxis (bleed from the nose)
  7. Hypercholesterolaemia (high levels of cholesterol in the blood)
  8. Pain
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Pruritus (severe itching of the skin)

50-59:

  1. Sinusitis (inflammation of sinus)
  2. Nausea (feeling of having an urge to vomit)
  3. Oedema peripheral (superficial swelling)
  4. Respiratory disorder (respiratory disease)
  5. Upper respiratory tract infection
  6. Abdominal discomfort
  7. Back pain
  8. Dizziness
  9. Foot deformity (functional disability of foot)
  10. Hand deformity

60+:

  1. Hypertension (high blood pressure)
  2. Injection site reaction
  3. Headache (pain in head)
  4. Hyperglycaemia (high blood sugar)
  5. Hyperpyrexia (extremely high fever)
  6. Hypotension (abnormally low blood pressure)
  7. Injection site haemorrhage (bleeding from injection site)
  8. Mottled skin (a condition in which the skin becomes discoloured in irregular patches)
  9. Multi-organ failure (multisystem organ failure)
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

* Approximation only. Some reports may have incomplete information.

Do you take Methyltestosterone and Enbrel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methyltestosterone and Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methyltestosterone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Enbrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methyltestosterone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Enbrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methyltestosterone and etanercept (the active ingredients of Methyltestosterone and Enbrel, respectively), and Methyltestosterone and Enbrel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: